Details for New Drug Application (NDA): 060666
✉ Email this page to a colleague
NDA 060666 describes TOTACILLIN, which is a drug marketed by Glaxosmithkline and is included in six NDAs. Additional details are available on the TOTACILLIN profile page.
The generic ingredient in TOTACILLIN is ampicillin sodium. There are seventy drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
The generic ingredient in TOTACILLIN is ampicillin sodium. There are seventy drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
Summary for 060666
| Tradename: | TOTACILLIN |
| Applicant: | Glaxosmithkline |
| Ingredient: | ampicillin/ampicillin trihydrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 125MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 250MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
